Annual Current Liabilities
$4.14 M
-$4.47 M-51.94%
December 31, 2023
Summary
- As of March 14, 2025, QLGN annual total current liabilities is $4.14 million, with the most recent change of -$4.47 million (-51.94%) on December 31, 2023.
- During the last 3 years, QLGN annual current liabilities has fallen by -$6.29 million (-60.34%).
- QLGN annual current liabilities is now -60.34% below its all-time high of $10.43 million, reached on December 1, 2020.
Performance
QLGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.45 M
-$358.50 K-7.45%
September 30, 2024
Summary
- As of March 14, 2025, QLGN quarterly total current liabilities is $4.45 million, with the most recent change of -$358.50 thousand (-7.45%) on September 30, 2024.
- Over the past year, QLGN quarterly current liabilities has dropped by -$71.10 thousand (-1.57%).
- QLGN quarterly current liabilities is now -80.72% below its all-time high of $23.10 million, reached on September 30, 2020.
Performance
QLGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
QLGN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.9% | -1.6% |
| 3 y3 years | -60.3% | -46.0% |
| 5 y5 years | -22.5% | - |
QLGN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.9% | at low | -48.3% | +22.8% |
| 5 y | 5-year | -60.3% | at low | -80.7% | +22.8% |
| alltime | all time | -60.3% | at low | -80.7% | +22.8% |
Qualigen Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.45 M(-7.4%) |
| Jun 2024 | - | $4.81 M(+6.4%) |
| Mar 2024 | - | $4.52 M(+9.4%) |
| Dec 2023 | $4.14 M(-51.9%) | $4.14 M(-30.6%) |
| Sep 2023 | - | $5.96 M(-29.9%) |
| Jun 2023 | - | $8.49 M(+3.0%) |
| Mar 2023 | - | $8.24 M(-4.2%) |
| Dec 2022 | $8.61 M | $8.61 M(+76.4%) |
| Sep 2022 | - | $4.88 M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $5.65 M(+55.7%) |
| Mar 2022 | - | $3.63 M(-21.8%) |
| Dec 2021 | $4.64 M(-55.6%) | $4.64 M(-14.6%) |
| Sep 2021 | - | $5.43 M(-26.8%) |
| Jun 2021 | - | $7.42 M(-19.4%) |
| Mar 2021 | - | $9.20 M(-60.2%) |
| Dec 2020 | $10.43 M(+95.3%) | - |
| Sep 2020 | - | $23.10 M(+8.7%) |
| Jun 2020 | - | $21.24 M |
| Mar 2020 | $5.34 M | - |
FAQ
- What is Qualigen Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual current liabilities year-on-year change?
- What is Qualigen Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly current liabilities year-on-year change?
What is Qualigen Therapeutics annual total current liabilities?
The current annual current liabilities of QLGN is $4.14 M
What is the all time high annual current liabilities for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual total current liabilities is $10.43 M
What is Qualigen Therapeutics annual current liabilities year-on-year change?
Over the past year, QLGN annual total current liabilities has changed by -$4.47 M (-51.94%)
What is Qualigen Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of QLGN is $4.45 M
What is the all time high quarterly current liabilities for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly total current liabilities is $23.10 M
What is Qualigen Therapeutics quarterly current liabilities year-on-year change?
Over the past year, QLGN quarterly total current liabilities has changed by -$71.10 K (-1.57%)